SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001539497-23-001240
Filing Date
2023-07-18
Accepted
2023-07-18 11:56:59
Documents
10
Period of Report
2023-08-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A n3660_x2-def14a.htm DEF 14A 265934
2 GRAPHIC n3660_x1-pre14aaimg001.jpg GRAPHIC 11681
3 GRAPHIC n3660_x1-pre14aaimg002.jpg GRAPHIC 7663
4 GRAPHIC n3660_x1-pre14aaimg003.jpg GRAPHIC 7052
5 GRAPHIC n3660_x1-pre14aaimg004.jpg GRAPHIC 2406
6 GRAPHIC n3660_x1-pre14aaimg005.jpg GRAPHIC 7669
7 GRAPHIC n3660_x1-pre14aaimg006.jpg GRAPHIC 1838
8 GRAPHIC n3660_x1-pre14aaimg007.jpg GRAPHIC 7453
9 GRAPHIC pc_1.jpg GRAPHIC 385367
10 GRAPHIC pc_2.jpg GRAPHIC 274754
  Complete submission text file 0001539497-23-001240.txt   1240499
Mailing Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729
Business Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729 512 896 1555
Molecular Templates, Inc. (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32979 | Film No.: 231093481
SIC: 2834 Pharmaceutical Preparations